Immunocore Holdings (Immunocore Holdings) Total Stockholders Equity : $456.8 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Total Stockholders Equity?

Immunocore Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $456.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Immunocore Holdings's Book Value per Share for the quarter that ended in Mar. 2024 was $9.14. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Immunocore Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.31.

Immunocore Holdings Total Stockholders Equity Historical Data

The historical data trend for Immunocore Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Total Stockholders Equity Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

19.36

74.39

228.12

412.79

466.89

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															332.64	350.09	360.82	466.89	456.84

Immunocore Holdings (NAS:IMCR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Immunocore Holdings's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(456.841	-	0)	/	50.0061
	=	9.14

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Immunocore Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.579	+	599.149)	/	456.841
	=	1.31

Immunocore Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.